Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Non-Current Debt (2020)

Historic Non-Current Debt for Ovid Therapeutics (OVID) over the last 1 years, with Q4 2020 value amounting to $61200.0.

  • Ovid Therapeutics' Non-Current Debt changed N/A to $61200.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $61200.0, marking a year-over-year change of. This contributed to the annual value of $61200.0 for FY2020, which is N/A changed from last year.
  • Ovid Therapeutics' Non-Current Debt amounted to $61200.0 in Q4 2020.
  • Over the past 5 years, Ovid Therapeutics' Non-Current Debt peaked at $286562.0 during Q1 2020, and registered a low of $61200.0 during Q3 2020.